Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $411.10 | 16 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $229.88 | 6 | $0 (2024) |
| ABBVIE INC. | $61.26 | 3 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $37.61 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $22.71 | 1 | $0 (2023) |
| Genentech USA, Inc. | $16.73 | 1 | $0 (2022) |
| Amgen Inc. | $14.65 | 1 | $0 (2024) |
| Novo Nordisk Inc | $14.51 | 1 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $13.75 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $371.66 | 14 | AstraZeneca Pharmaceuticals LP ($229.88) |
| 2023 | $22.71 | 1 | GlaxoSmithKline, LLC. ($22.71) |
| 2022 | $16.73 | 1 | Genentech USA, Inc. ($16.73) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Inflammation | ||||||
| 11/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Respiratory | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Respiratory | ||||||
| 08/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Cardio-renal | ||||||
| 07/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Respiratory | ||||||
| 06/28/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Respiratory | ||||||
| 05/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: NEUROSCIENCE | ||||||
| 04/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Diabetes | ||||||
| 03/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: NEUROSCIENCE | ||||||
| 02/26/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: UROLOGY | ||||||
| 02/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Cardio-renal | ||||||
| 02/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug), BREZTRI | Food and Beverage | In-kind items and services | $148.22 | General |
| Category: Respiratory | ||||||
| 05/30/2023 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: VACCINES | ||||||
| 01/10/2022 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Virology & Specialty Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 27 | 40 | $1,545 | $223.05 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 83036 | Hemoglobin a1c level | Office | 2023 | 12 | 15 | $420.00 | $142.80 | 34.0% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 15 | 25 | $1,125 | $80.25 | 7.1% |
About William Curry, PA-C
William Curry, PA-C is a Medical healthcare provider based in Atoka, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/23/2021. The National Provider Identifier (NPI) number assigned to this provider is 1205507985.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, William Curry, PA-C has received a total of $411.10 in payments from pharmaceutical and medical device companies, with $371.66 received in 2024. These payments were reported across 16 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($411.10).
As a Medicare-enrolled provider, Curry has provided services to 27 Medicare beneficiaries, totaling 40 services with total Medicare billing of $223.05. Data is available for 1 year (2023–2023), covering 2 distinct procedure/service records.
Practice Information
- Specialty Medical
- Location Atoka, TN
- Active Since 09/23/2021
- Last Updated 09/23/2021
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1205507985
Products in Payments
- AIRSUPRA (Drug) $209.55
- Kerendia (Drug) $37.61
- QULIPTA (Drug) $23.99
- BEXSERO (Biological) $22.71
- VRAYLAR (Drug) $22.05
- FARXIGA (Drug) $20.33
- Xofluza (Drug) $16.73
- UBRELVY (Drug) $15.22
- Otezla (Drug) $14.65
- Ozempic (Drug) $14.51
- GEMTESA (Drug) $13.75
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.